5th TPD and Induced Proximity Summit Europe 15Hatfields, London

Event Starts In

Set Reminder Submit

Induced proximity medicines are revolutionising therapeutic strategies, offering groundbreaking solutions for disease treatment.

In 2024 alone, PhoreMost secured $50 million in Series B financing for its degrader programs, while Merck KGaA partnered with C4 Therapeutics in a $756 million deal focused on protein degraders.

However, challenges remain in making PROTACs orally bioavailable, effectively discovering molecular glues, and developing non-degrading proximity therapeutics.

Join the The 5th TPD Summit Europe to network with over 100 experts and learn about the latest advancements in degraders (PROTACs, lysosomal, surface, and ECM), molecular glues, and non-degrading proximity therapeutics. Accelerate your research and bring innovative therapies to patients faster.

⌛ Event Dates & Venue

25 Mar - 27 Mar 2025, 9:00 am - 5:00 pm

Chadwick Court, England, United Kingdom, SE1 8DJ

👨‍👧‍👦 Social Networks

iCal

#_REVIEWS

💸 Website & Tickets

Go to Event Website

Ticket Pricing:
Drug Developer Pricing - Full Access Pass: GBP 3946.00, Drug Developer Pricing - Conference Only: GBP 2599.00, Academic and Not-For-Profit Pricing - Full Access Pass: GBP 3246.00, Academic and Not-For-Profit Pricing - Conference Only: GBP 1699.00, Service Provider Pricing - Full Access Pass: GBP 5196.00, Service Provider Pricing - Conference Only: GBP 3099.00

Buy Tickets